SIGLEC1 and central nervous system cancer: Fc-conjugated CD169 (CD169-Fc) bound to GL261 cells, confirming that GL261 glioma cells display the 2,3-sialylated glycoproteins or glycolipids recognized by CD169 (Supplementary Fig. 6a).